Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Sponsor
Groupe Francais De Pneumo-Cancerologie
Study ID
NCT00418704
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Erlotinib — DRUG
    Tarceva (150 mg) is a pill you take once a day -- every day
  • taxotere — DRUG
    Taxotere® (docetaxel) is given intravenously (I.V.) into the vein. Taxotere® chemotherapy treatment takes about one hour, and usually people receive treatments every three weeks.

Study Details

The purpose of this study is to determine duration before progression of first-line treatment chemotherapy following erlotinib in second-line comparing erlotinib in first-line following chemotherapy in second-line in old patients with none small cell lung cancer.

Key Dates

First listed
Jan 5, 2007
Start date
May 31, 2006
Status verified
Sep 2013
Primary completion
Jun 30, 2006
Completion
Jun 30, 2009

Study Design

Enrollment
100 participants (actual)

Related Studies